Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Alzheimer’s Disease

early stage alzheimers1 - symptoms of parkinson's3 - mini-mental state examination2 - the journal of neuroscience1 - good sleep habits1 - tetrahydrocannabinol1 - delusional misidentification1 - knopman1 - deep-brain stimulation3 - alzheimer’s patients1 - late-onset alzheimer's2 - postitron emission tomography1 - slowness of movement1 - alzheimers and parkinsons1 - bonfiglio1 - dementia-related diseases1 - sleep loss1 - myelination1 - broken bones1 - korsakoff's psychosis5 - vessel disease1 - living with dementia1 - diagnose parkinson's1 - congestive heart failure1 - cognitive health3 - encephalopathy-alcoholic10 - baroness thatcher1 - parkinson's dementia1 - terminal cognitive failure1 - late-day anxiety1 -